The 79th Annual Meeting of the Japanese Cancer Association

English

Secretariat

Department of Molecular Pathology,
Institute of Biomedical & Health Sciences Hiroshima University
1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima, Japan 734-8553

Congress Secretariat

Japan Convention Services, Inc. Kansai Branch
Keihanshin Yodoyabashi Bldg. 2F 4-4-7, Imabashi, Chuo-ku, Osaka 541-0042 Japan
E-mail: jca2020[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . )

Sponsored Seminar

Luncheon Seminar 1  Live

Oct. 1 (Thu.) 11:50-12:40 Room 3 RIHGA Royal Hotel Hiroshima 4F Crystal Hall

LS-1  Treatment and resistance of lung cancer with driver mutations

Chair Hirotoshi Akita (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University)
Speaker Seiji Yano (Division of Medical Oncology Cancer Research Institute, Kanazawa University)

Co-sponsored by: Chugai Pharmaceutical Co., LTD.

Luncheon Seminar 2  Live / On Demand

Oct. 1 (Thu.) 11:50-12:40 Room 4 RIHGA Royal Hotel Hiroshima 3F Miyajima

LS-2  
A novel three-dimensional culture for cancer research - Tissueoid cell culture system

Chair Satoshi Fujii (Department of Molecular Pathology, Yokohama City University Graduate School of Medicine)
Speaker Ken-ichi Mukaisho (Division of Human Pathology, Department of Pathology, Shiga University of Medical Science)

Co-sponsored by: Japan Vilene Company, Ltd.

Luncheon Seminar 3  Live / On Demand

Oct. 1 (Thu.) 11:50-12:40 Room 5 RIHGA Royal Hotel Hiroshima 3F Seto

LS-3  
The Breakthrough of BCMA-Targeted Immunotherapy in Treating Multiple Myeloma

Chair Alex Liu (GenScript Corporation)
Speaker Frank Fan (Legend Biotech Inc.)

Co-sponsored by: GenScript Corporation

Luncheon Seminar 4  Live

Oct. 1 (Thu.) 11:50-12:40 Room 7 HOTEL MIELPARQUE Hiroshima 6F Zuiun 1

LS-4  
Utility of CDK4/6 inhibitors in the treatment of breast cancer: from bench to clinics

Chair Maki Tanaka (JCHO Kurume General Hospital)
Speaker Junichi Kurebayashi (Department of Breast and Thyroid Surgery, Kawasaki Medical School)

Co-sponsored by: Eli Lilly Japan K.K.

Luncheon Seminar 5  Live / On Demand

Oct. 1 (Thu.) 11:50-12:40 Room 8 HOTEL MIELPARQUE Hiroshima 6F Zuiun 2

LS-5

Chair Yoshikatsu Koga (Exploratory Oncology Research & Clinical Trial Center, National Cancer Center)

Introduction of Fukushima patient derived tumor xenograft (F-PDX®)

Speaker1 Motoki Takagi (Fukushima Medical University / Fukushima Translational Research Foundation)

Current status and perspectives of patient-derived rare cancer models

Speaker2 Tadashi Kondo (Division of Rare Cancer Research, National Cancer Center Research Institute)

Co-sponsored by: Charles River Laboratories Japan, INC

Evening Seminar 1  Live / On Demand

Oct. 1 (Thu.) 15:30-16:20 Room 7 HOTEL MIELPARQUE Hiroshima 6F Zuiun 1

ES-1  The insider’s guide to Nature Cancer

Moderator Sayaka Yamane (Institutional Marketing, Springer Nature)
Speaker Alexia-Ileana Zaromytidou (Nature Cancer, Nature Research)

Co-sponsored by: Springer Nature

Luncheon Seminar 14  Live / On Demand

Oct. 2 (Fri.) 11:50-12:40 Room 2 RIHGA Royal Hotel Hiroshima 4F Royal Hall 3

LS-14  Single-cell landscape of antitumor immune responses

Chair Ken Osaki (10x Genomics)
Speaker Hiroshi Kagamu (Department of Respiratory Medicine, Saitama Medical University International Medical Center)

Co-sponsored by: Scrum Inc./ 10x Genomics

Luncheon Seminar 6  Live / On Demand

Oct. 2 (Fri.) 11:50-12:40 Room 3 RIHGA Royal Hotel Hiroshima 4F Crystal Hall

LS-6  
Multi-parametric analysis of antigen-specific T cells by using a super-multicolor flow cytometry

Chair Keisuke Yuki (BD Biosciences)
Speaker Hideki Ueno (Department of Immunology, Graduate School of Medicine, Kyoto University)

Co-sponsored by: Nippon Becton Dickinson Company, Ltd.

Luncheon Seminar 7  Live / On Demand

Oct. 2 (Fri.) 11:50-12:40 Room 4 RIHGA Royal Hotel Hiroshima 3F Miyajima

LS-7

Chair Tadashi Kondo (National Cancer Center Research Institute)

An in vitro system for evaluating anti-cancer drugs using patient-derived tumor organoids (F-PDO®)

Speaker Motoki Takagi (Fukushima Medical University)

Co-sponsored by: FUJIFILM Wako Pure Chemical Corporation

Luncheon Seminar 8  Live

Oct. 2 (Fri.) 11:50-12:40 Room 7 HOTEL MIELPARQUE Hiroshima 6F Zuiun 1

LS-8  Management and selection method of advanced gastric cancer chemotherapy

Chair Tatsuya Ioka (Yamaguchi University Hospital, Department of Oncology Center)
Speaker Hiroaki Tanioka (Department of Clinical Oncology, Kawasaki Medical School)

Co-sponsored by: TAIHO PHARMACEUTICAL CO., LTD.

Luncheon Seminar 9

Oct. 3 (Sat.) 11:50-12:40 Room 3 RIHGA Royal Hotel Hiroshima 4F Crystal Hall

LS-9  Development of cancer immunotherapy based on immunogenome analysis

Chair Takuya Tsunoda (Division of Medical Oncology, Department of Medicine, Showa University School of Medicine)
Speaker Hiroyoshi Nishikawa (Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center, National Cancer Center / Department of Immunology, Nagoya University Graduate School of Medicine)

Co-sponsored by: MSD K.K.

Luncheon Seminar 10  Live / On Demand

Oct. 3 (Sat.) 11:50-12:40 Room 4 RIHGA Royal Hotel Hiroshima 3F Miyajima

LS-10  Advanced T Cell Analytics Using Digital Cell Biology at Light Speed

Chair Yasujiro Kiyota (Nikon Corporation)
Speaker Yue Geng (Berkeley Lights Inc.)

Co-sponsored by: Nikon Corporation

Luncheon Seminar 11  Live / On Demand

Oct. 3 (Sat.) 11:50-12:40 Room 5 RIHGA Royal Hotel Hiroshima 3F Seto

LS-11  RNA Expression and Methylation in Liquid Biopsy

Chair Takahiro Ochiya (Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University)
Speaker Hideshi Ishii (Department of Medical Data Science, Graduate School of Medicine, Osaka University)

Co-sponsored by: Toray Industries, Inc,

Luncheon Seminar 12  Live / On Demand

Oct. 3 (Sat.) 11:50-12:40 Room 7 HOTEL MIELPARQUE Hiroshima 6F Zuiun 1

LS-12  Cancer Genomics -implication of whole genome sequencing-

Chair Hideki Hanaoka (Regional Segment Marketing, Illumina K.K.)
Speaker Ken Yamaguchi (Shizuoka Cancer Center)

Co-sponsored by: Illumina K.K.

Luncheon Seminar 13  Live

Oct. 3 (Sat.) 11:50-12:40 Room 8 HOTEL MIELPARQUE Hiroshima 6F Zuiun 2

LS-13  Development of treatment strategy for HER2-positive breast cancer

Chair Masakazu Toi (Kyoto University)
Speaker Yasuo Miyoshi (Department of Breast and Endocrine Surgery Hyogo, College of Medicine)

Co-sponsored by: DAIICHI SANKYO COMPANY, LIMITED

page top